Galmed Pharmaceuticals Ltd. — Investor Relations & Filings
Galmed Pharmaceuticals Ltd. is a clinical-stage biopharmaceutical company that develops therapeutics for liver, metabolic, and inflammatory diseases. The company's primary focus is on its lead product candidate, Aramchol, an oral therapy for the treatment of metabolic dysfunction-associated steatohepatitis (MASH). Aramchol is being evaluated in late-stage clinical trials, such as the ARMOR Phase 3 study, both as a monotherapy and in combination with other treatments. The company has also announced an expansion of its development activities to include cancer and other major cardiometabolic diseases.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 6-K - Galmed Pharmaceuticals Ltd. (0001595353) (Filer) | 2026-04-14 | English | |
| 6-K - Galmed Pharmaceuticals Ltd. (0001595353) (Filer) | 2026-04-09 | English | |
| 3 - Galmed Pharmaceuticals Ltd. (0001595353) (Issuer) | 2026-03-18 | English | |
| 3 - Galmed Pharmaceuticals Ltd. (0001595353) (Issuer) | 2026-03-18 | English | |
| 3 - Galmed Pharmaceuticals Ltd. (0001595353) (Issuer) | 2026-03-18 | English | |
| 3 - Galmed Pharmaceuticals Ltd. (0001595353) (Issuer) | 2026-03-18 | English |
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Galmed Pharmaceuticals Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35309/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35309 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35309 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35309 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35309}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Galmed Pharmaceuticals Ltd. (id: 35309)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.